Target intelligence / Profile preview

Cytochrome c oxidase associated subunit FA4 (COXFA4)

Target
COXFA4
Molecular classification
Enzyme subunit (respiratory chain), Component of cytochrome c oxidase (complex IV, mitochondrial electron transport chain), Mitochondrial membrane protein
01

Overview

Cytochrome c oxidase associated subunit FA4 (COXFA4), formerly known as NDUFA4, is a small transmembrane protein component of cytochrome c oxidase (Complex IV), the terminal enzyme of the mitochondrial electron transport chain, which is essential for oxidative phosphorylation and ATP generation. COXFA4 was originally thought to be a subunit of complex I, but it is now well established as a subunit of complex IV. COXFA4 is required for maximal Complex IV enzymatic activity in select cell types. Recent research has uncovered a dynamic regulation of COXFA4, where, in response to inflammation or hypoxia, it can be replaced by related proteins such as C15ORF48 via a switch regulated at both mRNA and protein levels. Loss-of-function mutations in NDUFA4 cause a mitochondrial disease resembling Leigh syndrome, marked by neuromuscular symptoms, impaired complex IV activity, and lactic acidosis. COXFA4 plays a role in regulating the assembly and function of cytochrome c oxidase and may have wider implications in inflammatory and metabolic diseases, but no drugs specifically target this subunit in clinical practice.

Other names
NDUFA4Cytochrome c oxidase subunit NDUFA4CI-MLRQMLRQCI-9kMRCAF1MISTR1Complex I-MLRQNADH-ubiquinone oxidoreductase MLRQ subunitComplex I 9kDa subunitMitochondrial respiratory chain associated factor 1Mitochondrial stress response 1NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDaNDUFA4 mitochondrial complex associatedMC4DN21
02

Mechanism of action

Not applicable: no selective drugs targeting COXFA4 are known. Drugs that inhibit Complex IV (such as cyanide) inhibit the whole enzyme complex, not COXFA4 individually

03

Biological functions

Oxidative phosphorylationElectron transport chainMitochondrial respirationRegulation of energy generationCellular response to inflammation and hypoxia
04

Disease associations

Mitochondrial disease (e.g., Leigh syndrome-like neuromuscular disorder from loss-of-function mutations)Neurodegenerative diseaseInflammation (including rheumatoid arthritis, COVID-19 pathogenic macrophage activation)Possibly other pathological mitochondrial dysfunctions
05

Safety considerations

Loss of function causes severe mitochondrial disease, including muscle and neurological impairmentNon-specific inhibitors of cytochrome c oxidase are toxic due to disruption of cellular respiration.
06

Interacting drugs

None uniquely specific to COXFA4 identified. However, mitochondrial electron transport inhibitors (e.g., cyanide, azide) can inhibit Complex IV activity as a whole. No clinically approved drugs appear to act specifically on COXFA4
07

Biomarkers

Loss-of-function mutation in NDUFA4 gene as a potential diagnostic marker for rare, severe Leigh syndrome-like neuromuscular disorderUpregulation or replacement by C15ORF48 in proinflammatory/macrophage metabolic states may be of future biomarker interest in inflammatory diseases (RA, COVID-19), but clinical use not established

Beyond the preview

Go deeper on Cytochrome c oxidase associated subunit FA4 (COXFA4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c oxidase associated subunit FA4 (COXFA4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call